Two gout experts debated whether first-line urate-lowering therapy should consist of a xanthine oxidase inhibitor or should ...

Million Senior Secured Term Loan Credit Facility and New $100 Million Convertible Note to Repay Significant Portion of Existing $265 ...

5 The safety profile of luspatercept was consistent with previous studies. Safety assessments show treatment-emergent adverse ...

[18] It is also an adrenolytic agent at doses greater than 4 g per day, and is used most often for the treatment of adrenocortical carcinoma. ACTH: Adrenocorticotrophic hormone; b.i.d.: Twice ...

上海, 2024年12月17日 - (亚太商讯) - 云顶新耀（HKEX 1952.HK）是一家专注于创新药研发、临床开发、制造和商业化的生物制药公司，今日宣布中国国家药品监督管理局已正式受理伊曲莫德（VELSIPITY(R)）用于治疗中重度活动性溃疡性结肠炎（UC）患者的新药上市许可 ...